US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

crane

186.61

-0.0600-0.03%

Post-market: 187.000.3900+0.21%16:29 EDT

Volume:409.98K

Turnover:76.61M

Market Cap:10.73B

PE:32.38

High:188.95

Open:186.62

Low:185.32

Close:186.67

Loading ...

Overview Company News Filings

Press Release: ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update

Press Release: SELLAS Life Sciences Reports First Quarter 2025 Financial Results and Provides Corporate Update

Press Release: CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

Crane Is Maintained at Hold by Stifel

Deutsche Bank Lifts Price Target on Crane to $187 From $186, Keeps Buy Rating

MT Newswires Live

CERo Therapeutics Holdings, Inc. Announces TriStar Centennial Medical Center as a Clinical Trial Site for its Phase 1 Clinical Trial of CER-1236 in Acute Myeloid Leukemia

Crane Co (CR) Q1 2025 Earnings Call Highlights: Strong Core Sales Growth and Record Backlog ...

Q1 2025 Crane Co Earnings Call

Thomson Reuters StreetEvents

Crane Company Shares Rise After Upgrade From UBS

MT Newswires Live

Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday

Crane Co : UBS Raises to Buy From Neutral; Raises Target Price to $190 From $157

THOMSON REUTERS

UBS Upgrades Crane to Buy From Neutral

MT Newswires Live

Crane Raised to Buy From Neutral by UBS

BioInvent Receives FDA Fast Track Designation for BI-1808 for the Treatment of Cutaneous T-cell Lymphoma

ACCESS Newswire

Crane 1Q Profit Soars on Higher Revenue

Crane Co reports results for the quarter ended March 31 - Earnings Summary

Crane Holdings Q1 Adj. EPS $1.39 Beats $1.31 Estimate, Sales $557.60M Beat $547.96M Estimate

BRIEF-Crane Company Q1 Sales USD 557.6 Million Vs. IBES Estimate USD 548 Million

Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025

CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CR\",,,,,undefined,":{"symbol":"CR","market":"US","secType":"STK","nameCN":"crane","latestPrice":186.61,"timestamp":1749672000000,"preClose":186.67,"halted":0,"volume":409984,"hourTrading":{"tag":"盘后","latestPrice":187,"preClose":186.61,"latestTime":"16:29 EDT","volume":7903,"amount":1474779.46224,"timestamp":1749673796822},"delay":0,"floatShares":48719860,"shares":57501189,"eps":5.763835,"marketStatus":"Post-Mkt","change":-0.06,"latestTime":"06-11 19:37:46 EDT","open":186.62,"high":188.95,"low":185.32,"amount":76605268.58703,"amplitude":0.019446,"askPrice":196.21,"askSize":2,"bidPrice":185.52,"bidSize":45,"shortable":3,"etf":0,"ttmEps":5.763835,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1749686400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":186.67,"dividendRate":0.004528,"preHourTrading":{"tag":"盘前","latestPrice":188.5,"preClose":186.605,"latestTime":"09:13 EDT","volume":175,"amount":32983.09875,"timestamp":1749647637679},"postHourTrading":{"tag":"盘后","latestPrice":187,"preClose":186.61,"latestTime":"16:29 EDT","volume":7903,"amount":1474779.46224,"timestamp":1749673796822},"volumeRatio":1.112657,"impliedVol":0.2805,"impliedVolPercentile":0.008},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CR\",,,,,undefined,":{"symbol":"CR","floatShares":48719860,"roa":"8.85%","roe":"18.17%","lyrEps":5.152097,"volumeRatio":1.112657,"shares":57501189,"dividePrice":0.845,"high":188.95,"amplitude":0.019446,"preClose":186.67,"low":185.32,"week52Low":127.04,"pbRate":"6.11","psRate":"4.93","week52High":191,"institutionHeld":0.6875,"latestPrice":186.61,"committee":0.914894,"eps":5.763835,"divideRate":0.004528,"volume":409984,"delay":0,"ttmEps":5.763835,"open":186.62,"prevYearClose":151.75,"prevWeekClose":177.68,"prevMonthClose":171.4,"prevQuarterClose":153.18,"fiveDayClose":175.12,"twentyDayClose":175.89,"sixtyDayClose":154.44},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535025235","title":"Press Release: ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2535025235","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535025235?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:00","pubTimestamp":1747224000,"startTime":"0","endTime":"0","summary":"LOTIS-7 abstract accepted for presentation at the European Hematology Association 2025 Congress  and the 18 International Conference on Malignant Lymphoma ; ZYNLONTA plus glofitamab demonstrated ORR of 95.5% and CR of 90.9% with encouraging safety and tolerability. Cash runway expected to fund multiple catalysts into the second half of 2026. LAUSANNE, Switzerland, May 14, 2025 /PRNewswire/ -- ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates , today reported financial results for the first quarter ended March 31, 2025, and provided recent operational updates.\"We are encouraged by the promising LOTIS-7 abstract data, which we believe demonstrate the potential for ZYNLONTA plus glofitamab to be a best-in-class combination in a dynamic market,\" said Ameet Mallik, Chief Executive Officer of ADC Therapeutics. \"Coupled with the progress of our LOTIS-5 confirmatory trial, we are confident in our path forward and the potential of ZYNLON","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4161","BK4007","CR","BK4080","PFS","ADC","BK4539","BK4022","R","ORR","BK4231","BK4139","BK4195","BK4232","PBD","ADCT","BK4211","BK4505"],"gpt_icon":0},{"id":"2535084331","title":"Press Release: SELLAS Life Sciences Reports First Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2535084331","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535084331?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:05","pubTimestamp":1747166700,"startTime":"0","endTime":"0","summary":"-- SLS009 Shows Promising Efficacy in Pediatric Acute Lymphoblastic Leukemia  Xenograft Models --. -- Final Analysis of Pivotal Phase 3 REGAL Trial of Galinpepimut-S  in AML Anticipated in 2025 --. -- $28.4 million in Cash and Cash Equivalents as of March 31, 2025; Additional $4.0 million Proceeds received in April 2025 through Warrant Exercises --. NEW YORK, May 13, 2025  -- SELLAS Life Sciences Group, Inc.  , a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today reported financial results for the first quarter ended March 31, 2025, and provided a corporate update.Presented Preclinical Data Highlighting Efficacy of SLS009 in TP53 Mutated AML at the 2025 AACR Conference: Preclinical data suggest tha","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","CR","BK4213","BK4107","OS","BK4097","BK4232","BK4139","SLS","BK4588","BK4022","BK4585","ORR","PDX","LU1571399168.USD","LU2355687059.USD","LU0985320562.USD","LU1699723380.USD","R","BK4161","ALL","PR"],"gpt_icon":0},{"id":"2535279547","title":"Press Release: CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2535279547","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535279547?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:00","pubTimestamp":1747137600,"startTime":"0","endTime":"0","summary":"- Updated BOND-003 clinical results presented at AUA showing best-in-disease durability and tolerability data for Cohort C with 24-month complete response rate of 42.3% by K-M -. - Promising early signal in Cohort P with 90.5% high-grade recurrence free survival at 3 and 9 months by K-M -. - Initiated CORE-008 Cohort CX evaluating the combination of cretostimogene and gemcitabine in patients with high-risk  BCG-exposed NMIBC -. \"In 2025, we made further progress advancing cretostimogene monotherapy as a bladder-sparing backbone therapy for patients with NMIBC,\" said Arthur Kuan, Chairman & Chief Executive Officer at CG Oncology. \"With best-in-disease durability and tolerability data from the BOND-003 Cohort C registrational trial recently presented at AUA, we are well positioned to initiate our BLA submission in the second half of the year for the treatment of patients with HR NMIBC unresponsive to BCG. Our clinical programs have been carefully designed to address different stages of b","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","US30Y.BOND","BK4203","IE00BGHQF748.EUR","US3Y.BOND","US5Y.BOND","CR","BK4161","HR","IE00B64PRP62.GBP","CGON","US2Y.BOND","CG","US7Y.BOND","IE00B3QW5Z07.USD","BK4135","US10Y.BOND","US6M.BOND","US12M.BOND","BK4225"],"gpt_icon":0},{"id":"2532063006","title":"Crane Is Maintained at Hold by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2532063006","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532063006?lang=en_us&edition=fundamental","pubTime":"2025-05-01 00:51","pubTimestamp":1746031860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 30, 2025 12:51 ET (16:51 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SF","CR","BK4127","BK4161"],"gpt_icon":0},{"id":"2531037794","title":"Deutsche Bank Lifts Price Target on Crane to $187 From $186, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2531037794","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531037794?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:53","pubTimestamp":1746017636,"startTime":"0","endTime":"0","summary":"Crane (CR) has an average rating of overweight and mean price target of $186, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DB","CR"],"gpt_icon":0},{"id":"2531203126","title":"CERo Therapeutics Holdings, Inc. Announces TriStar Centennial Medical Center as a Clinical Trial Site for its Phase 1 Clinical Trial of CER-1236 in Acute Myeloid Leukemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2531203126","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531203126?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:15","pubTimestamp":1746015300,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., April 30, 2025  -- CERo Therapeutics Holdings, Inc.,   an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces that TriStar Centennial Medical Center, through Sarah Cannon Research Institute , in Nashville, Tennessee, is a clinical trial site for the Company’s Phase 1 clinical of CER-1236. Collaborating with SCRI to advance cancer research, TriStar Centennial offers innovative clinical research trials for various disease indications. The trial is focused on patients with acute myeloid leukemia , and patient enrollment is underway, with expected dosing of the first patient during the first half of 2025.CERo is an innovative immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cero-therapeutics-holdings-inc-announces-121500799.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4161","CR","CERO","CEROW","ORR","BK4139","BK4181","BK4218","PK"],"gpt_icon":0},{"id":"2531870569","title":"Crane Co (CR) Q1 2025 Earnings Call Highlights: Strong Core Sales Growth and Record Backlog ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2531870569","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531870569?lang=en_us&edition=fundamental","pubTime":"2025-04-30 15:13","pubTimestamp":1745997203,"startTime":"0","endTime":"0","summary":"Adjusted EPS: $1.39, driven by 7.5% core sales growth.Core Orders Growth: Up 16% in the quarter.Full Year 2025 Adjusted EPS Outlook: Reaffirmed in the range of $5.30 to $5.60.Aerospace and Electronics Sales: $249 million, a 10% increase, all organic growth.Aerospace and Electronics Backlog: Record high of $960 million, up 21% year-over-year.Adjusted Segment Margin for Aerospace and Electronics: 26%, a record high, up 360 basis points from last year.Process Flow Technologies Sales: $309 million, up 9%, with 5% core sales growth.Adjusted Operating Margin for Process Flow Technologies: 20.9%, expanded by 10 basis points.Core Operating Leverage for Process Flow Technologies: 35%, at the high end of the targeted range.Corporate Expense: $25 million in the quarter, with an expectation of $80 million for the full year.GuruFocus has detected 3 Warning Sign with CR.Core orders increased by 16% in the quarter, primarily due to strong performance in the Aerospace and Electronics segment.Crane Co ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/crane-co-cr-q1-2025-071323393.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CR"],"gpt_icon":0},{"id":"2531677824","title":"Q1 2025 Crane Co Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2531677824","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531677824?lang=en_us&edition=fundamental","pubTime":"2025-04-30 12:59","pubTimestamp":1745989188,"startTime":"0","endTime":"0","summary":"Allison Poliniak; Vice President, Investor Relations; Crane Co. Max Mitchell; President, Chief Executive Officer, Director; Crane Co. Alejandro Alcala; Executive Vice President, Chief Operating Officer; Crane Co. Richard Maue; Chief Financial Officer, Executive Vice President; Crane Co. Thank you, Allison, and thanks, everyone, for joining the call today. May you live in interesting times. The origins of the phrase are unknown, but we've all heard of it used as a forecasted euphemism for times of challenge and uncertainty, something gets intended more of a curse. But either way, it's times like these that we prepare for at Crane. As a leader with a global diversified manufacturer and for my entire team, what a fantastic time for us to continue to hone our strategic thinking, processes for reacting to fast changing events, and our ability to execute in an environment that's in constant flux. And have experienced the whole team embraces and relishes in this environment as we continue to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q1-2025-crane-co-earnings-045948114.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CR"],"gpt_icon":0},{"id":"2531239767","title":"Crane Company Shares Rise After Upgrade From UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2531239767","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531239767?lang=en_us&edition=fundamental","pubTime":"2025-04-30 02:16","pubTimestamp":1745950580,"startTime":"0","endTime":"0","summary":"Crane Company (CR) shares rose as much as 9.2% in intraday trading on Tuesday after UBS upgraded the stock to buy from neutral.Trading volume stood at over 460,000 shares against a daily average of about 337,000.Price: 157.40, Change: +8.73, Percent Change: +5.87","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CR"],"gpt_icon":0},{"id":"2531593477","title":"Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2531593477","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531593477?lang=en_us&edition=fundamental","pubTime":"2025-04-29 22:36","pubTimestamp":1745937392,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/04/45070499/honeywell-posts-better-than-expected-q1-earnings-joins-crown-holdings-noble-crane-and-other-big-stocks-moving-higher-on-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KNSA","NE","NBL","EPWK","CCK","MTSR","FOUR","LZMH","HON","TRS","LEG","PUMP","CR","CECO","CLVT"],"gpt_icon":1},{"id":"2531563277","title":"Crane Co : UBS Raises to Buy From Neutral; Raises Target Price to $190 From $157","url":"https://stock-news.laohu8.com/highlight/detail?id=2531563277","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531563277?lang=en_us&edition=fundamental","pubTime":"2025-04-29 22:24","pubTimestamp":1745936668,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R71U0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CR","BK4161"],"gpt_icon":0},{"id":"2531452733","title":"UBS Upgrades Crane to Buy From Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2531452733","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531452733?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:27","pubTimestamp":1745929659,"startTime":"0","endTime":"0","summary":"Crane Company (CR) has an average rating of overweight and mean price target of $185, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CR"],"gpt_icon":0},{"id":"2531738145","title":"Crane Raised to Buy From Neutral by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2531738145","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531738145?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:12","pubTimestamp":1745928720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 29, 2025 08:12 ET (12:12 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CR"],"gpt_icon":0},{"id":"2531557200","title":"BioInvent Receives FDA Fast Track Designation for BI-1808 for the Treatment of Cutaneous T-cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2531557200","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531557200?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:15","pubTimestamp":1745921700,"startTime":"0","endTime":"0","summary":"LUND, SE / ACCESS Newswire / April 29, 2025 / BioInvent International AB  , a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announces that the U.S. Food and Drug Administration  has granted Fast Track Designation to BI-1808, a first-in-class anti-TNFR2 antibody, for the treatment of adults with relapsed or refractory mycosis fungoides and Sézary syndrome, subtypes of cutaneous T-cell lymphoma . Fast Track Designation  is intended to facilitate the development and review of drugs that treat serious conditions.About Phase 1/2a studyDuring the first part of the Phase 1/2a study  the safety, tolerability, and potential signs of efficacy of BI-1808 as a single agent  and in combination with the anti-PD-1 therapy pembrolizumab  are evaluated in patients with advanced solid tumors and T-cell lymphoma. The efficacy of BI-1808 as single agent is currently explored in the Phase 2a part of the tria","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioinvent-receives-fda-fast-track-101500462.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CR","BOVNF","BK4161","BK4213","BK4139","SD","FAST","PR"],"gpt_icon":0},{"id":"2531426716","title":"Crane 1Q Profit Soars on Higher Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2531426716","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531426716?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:56","pubTimestamp":1745877360,"startTime":"0","endTime":"0","summary":"Crane produced a higher profit in the first quarter as its core sales increased and productivity efforts helped bolster the bottom line.The maker of industrial products posted a profit of $107.1 million, or $1.83 a share, compared with $64.8 million, or $1.12 a share, in the same period a year earlier.Stripping out one-time items, adjusted earnings were $1.39 a share. Analysts polled by FactSet had been expecting $1.31 a share.Sales rose 9% to $557.6 million, topping analyst forecasts for $548 million, according to FactSet.Most of that growth came from higher core sales, though acquisitions provided a boost as well. Higher productivity and volumes contributed to the jump in earnings, Crane said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CR"],"gpt_icon":0},{"id":"2531267163","title":"Crane Co reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2531267163","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531267163?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:55","pubTimestamp":1745877303,"startTime":"0","endTime":"0","summary":"Crane Co reports results for the quarter ended March 31 - Earnings SummaryCrane Co CR.N reported quarterly adjusted earnings of $1.88 per share for the quarter ended March 31, higher than the same qua","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL8N3R62J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CR"],"gpt_icon":0},{"id":"2531268789","title":"Crane Holdings Q1 Adj. EPS $1.39 Beats $1.31 Estimate, Sales $557.60M Beat $547.96M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2531268789","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531268789?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:17","pubTimestamp":1745871453,"startTime":"0","endTime":"0","summary":"Crane Holdings (NYSE:CR) reported quarterly earnings of $1.39 per share which beat the analyst consensus estimate of $1.31 by 6.11 percent. This is a 24.11 percent increase over earnings of $1.12 per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/04/45052774/crane-holdings-q1-adj-eps-1-39-beats-1-31-estimate-sales-557-60m-beat-547-96m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CR"],"gpt_icon":0},{"id":"2531268238","title":"BRIEF-Crane Company Q1 Sales USD 557.6 Million Vs. IBES Estimate USD 548 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2531268238","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531268238?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:15","pubTimestamp":1745871346,"startTime":"0","endTime":"0","summary":"BRIEF-Crane Company Q1 Sales USD 557.6 Million Vs. IBES Estimate USD 548 Million\n\n\nApr 28 (Reuters) - Crane Company outlook FY adjusted EPS USD 5.3-5.6.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nPLXE1ABE2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CR"],"gpt_icon":0},{"id":"2531558002","title":"Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531558002","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531558002?lang=en_us&edition=fundamental","pubTime":"2025-04-29 01:38","pubTimestamp":1745861880,"startTime":"0","endTime":"0","summary":"90% of patients achieved high grade disease-free status at any time point with NDV-01, demonstrating strong proof-of-concept for sustained-release “GEM/DOCE” formulation*. NDV-01 showed promising clinical activity in BCG-nave and BCG-unresponsive patients, with favorable overall tolerability. Data to be reviewed at Investor Event on April 28, 2025 at 4:30 PM ET. CORAL GABLES, Fla., April 28, 2025  -- Relmada Therapeutics, Inc. , a clinical-stage biotechnology company, today announced that positive initial data from the Phase 2 study of NDV-01 showed that 90% of patients achieved high-grade disease-free status at any time point following treatment, demonstrating strong clinical activity and supporting further development of NDV-01 for the treatment of non-muscle invasive bladder cancer . The data were presented today at the American Urology Association 2025  Annual Meeting with a data cutoff date of April 20, 2025. To register for the virtual Investor Event, click here.Overall: The trea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/relmada-therapeutics-presents-positive-initial-173800225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RLMD","CR","ORR","BK4139","BK4007","BK4161","LENZ"],"gpt_icon":0},{"id":"2531912232","title":"CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2531912232","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531912232?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:14","pubTimestamp":1745853277,"startTime":"0","endTime":"0","summary":"CG Oncology, Inc.  announced on Saturday that cretostimogene grenadenorepvec monotherapy data were presented at the 2025 American Urological Association Annual Meeting.The Phase 3 BOND-003 Cohort C study is in patients with high-risk non-muscle invasive bladder cancer  unresponsive to Bacillus Calmette Guerin  treatment with carcinoma in situ  with or without Ta or T1 disease.The study reported 75.5% complete response  at any time, with 34 confirmed CRs at 24 months and nine patients pending their 24-month assessment as of the March 14, 2025, cutoff date.Also Read: ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug. The 12—and 24-month CR rates are 50.7% and 42.3%, respectively, by K-M estimation.The median duration of response  is 28 months and ongoing. Notably, 97.3% of patients were free from progression to muscle-invasive disease at 24 months.Additionally, Cohort P, in patients with BCG-unresponsive Ta/T1 disease without CIS, showed an estimated 90.5% high-grade r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cg-oncologys-bladder-cancer-drug-151437058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ISBC","CGON","CG","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BCG","BK4135","CR","BK4139","IE00B3QW5Z07.USD","BK4161","BK4211"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CR\",params:#limit:5,,,undefined,":[{"date":"2025-05-30","symbol":"CR","amount":0.23,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-30","defaultRemindTime":1748611800000,"name":"crane","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-11","payableDate":"2025-05-30","currency":"USD","dateTimestamp":1748577600000,"payDate":"2025-06-11"},{"market":"US","date":"2025-04-28","symbol":"CR","fiscalQuarterEnding":"2025/03","expectedEps":1.29,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745812800000,"reportTimeType":"post","actualEps":1.39},{"date":"2025-02-28","symbol":"CR","amount":0.23,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-28","defaultRemindTime":1740753000000,"name":"crane","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-12","payableDate":"2025-02-28","currency":"USD","dateTimestamp":1740718800000,"payDate":"2025-03-12"},{"market":"US","date":"2025-01-27","symbol":"CR","fiscalQuarterEnding":"2024/12","expectedEps":1.19,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1737954000000,"reportTimeType":"post","actualEps":1.26},{"date":"2024-11-29","symbol":"CR","amount":0.205,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-29","defaultRemindTime":1732890600000,"name":"crane","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-11","payableDate":"2024-11-29","currency":"USD","dateTimestamp":1732856400000,"payDate":"2024-12-11"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CR\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-24","recordDate":"2017-02-28","paymentDate":"2017-03-09","value":0.33,"currency":"USD"},{"executeDate":"2017-05-26","recordDate":"2017-05-31","paymentDate":"2017-06-09","value":0.33,"currency":"USD"},{"executeDate":"2017-08-29","recordDate":"2017-08-31","paymentDate":"2017-09-08","value":0.33,"currency":"USD"},{"executeDate":"2017-11-29","recordDate":"2017-11-30","paymentDate":"2017-12-08","value":0.33,"currency":"USD"},{"executeDate":"2018-02-27","recordDate":"2018-02-28","paymentDate":"2018-03-09","value":0.35,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1111,"buy":0.7778,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7778,"analysts":9,"updateTime":1745985600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CR","date":"2025-06-10","current":31.734855,"percent":0.742067,"low":8.74154,"twenty":14.045214,"median":24.915132,"eighty":35.772714,"high":224.415426,"avg":34.005267,"sd":39.659472,"marketCap":10694646142},"quantilePoints":[{"date":"2020-06-12","current":28.05608,"twenty":14.741964,"median":19.280168,"eighty":26.565059,"marketCap":3189976299},{"date":"2020-06-19","current":28.040782,"twenty":14.741964,"median":19.30144,"eighty":26.931579,"marketCap":3188236945},{"date":"2020-06-26","current":28.73428,"twenty":14.741964,"median":19.376127,"eighty":27.12269,"marketCap":3267087686},{"date":"2020-07-02","current":29.529764,"twenty":14.741964,"median":19.392132,"eighty":27.321969,"marketCap":3357534124},{"date":"2020-07-10","current":27.913301,"twenty":14.741964,"median":19.430021,"eighty":27.459735,"marketCap":3173742323},{"date":"2020-07-17","current":30.717889,"twenty":14.741964,"median":19.444135,"eighty":27.610101,"marketCap":3492623996},{"date":"2020-07-24","current":30.891264,"twenty":14.741964,"median":19.472413,"eighty":27.833259,"marketCap":3512336681},{"date":"2020-07-31","current":87.533402,"twenty":14.74899,"median":19.495965,"eighty":27.94019,"marketCap":3282502591},{"date":"2020-08-07","current":93.258585,"twenty":14.767286,"median":19.525503,"eighty":28.009625,"marketCap":3497196945},{"date":"2020-08-14","current":94.264361,"twenty":14.787765,"median":19.544175,"eighty":28.04746,"marketCap":3534913520},{"date":"2020-08-21","current":87.719084,"twenty":14.813662,"median":19.570486,"eighty":28.081529,"marketCap":3289465651},{"date":"2020-08-28","current":90.040104,"twenty":14.83771,"median":19.594842,"eighty":28.170784,"marketCap":3376503903},{"date":"2020-09-04","current":88.260655,"twenty":14.871894,"median":19.605519,"eighty":28.267865,"marketCap":3309774577},{"date":"2020-09-11","current":84.237554,"twenty":14.936445,"median":19.626415,"eighty":28.310525,"marketCap":3158908274},{"date":"2020-09-18","current":81.978428,"twenty":15.011846,"median":19.656053,"eighty":28.373051,"marketCap":3074191042},{"date":"2020-09-25","current":76.779343,"twenty":15.041272,"median":19.669528,"eighty":28.409968,"marketCap":2879225359},{"date":"2020-10-02","current":76.965025,"twenty":15.066218,"median":19.682881,"eighty":28.47471,"marketCap":2886188419},{"date":"2020-10-09","current":80.137085,"twenty":15.081973,"median":19.70422,"eighty":28.560476,"marketCap":3005140696},{"date":"2020-10-16","current":84.253027,"twenty":15.124703,"median":19.713849,"eighty":28.62779,"marketCap":3159488529},{"date":"2020-10-23","current":85.320697,"twenty":15.162424,"median":19.729877,"eighty":28.703268,"marketCap":3199526125},{"date":"2020-10-30","current":136.527006,"twenty":15.223621,"median":19.752233,"eighty":28.737446,"marketCap":2948983334},{"date":"2020-11-06","current":142.122596,"twenty":15.260409,"median":19.772138,"eighty":28.792366,"marketCap":3069848070},{"date":"2020-11-13","current":165.258207,"twenty":15.260409,"median":19.790516,"eighty":28.85843,"marketCap":3569577265},{"date":"2020-11-20","current":177.390952,"twenty":15.260409,"median":19.802914,"eighty":28.931965,"marketCap":3831644553},{"date":"2020-11-27","current":191.003299,"twenty":15.260409,"median":19.824132,"eighty":28.993533,"marketCap":4125671266},{"date":"2020-12-04","current":198.293707,"twenty":15.260409,"median":19.834923,"eighty":29.072788,"marketCap":4283144070},{"date":"2020-12-11","current":204.884666,"twenty":15.277405,"median":19.845593,"eighty":29.204431,"marketCap":4425508783},{"date":"2020-12-18","current":208.059087,"twenty":15.319129,"median":19.880269,"eighty":29.408025,"marketCap":4494076277},{"date":"2020-12-24","current":206.848503,"twenty":15.339718,"median":19.900532,"eighty":29.534806,"marketCap":4467927656},{"date":"2020-12-31","current":208.919947,"twenty":15.365764,"median":19.915811,"eighty":29.796111,"marketCap":4512670852},{"date":"2021-01-08","current":218.147289,"twenty":15.386249,"median":19.927575,"eighty":30.133245,"marketCap":4711981450},{"date":"2021-01-15","current":217.178822,"twenty":15.463133,"median":19.955186,"eighty":30.348098,"marketCap":4691062553},{"date":"2021-01-22","current":216.990509,"twenty":15.518993,"median":19.983043,"eighty":30.612845,"marketCap":4686994990},{"date":"2021-01-29","current":24.296226,"twenty":15.546124,"median":20.000911,"eighty":30.612845,"marketCap":4397616921},{"date":"2021-02-05","current":26.22567,"twenty":15.604175,"median":20.036867,"eighty":30.612845,"marketCap":4746846277},{"date":"2021-02-12","current":26.752174,"twenty":15.64869,"median":20.047071,"eighty":30.612845,"marketCap":4842143473},{"date":"2021-02-19","current":27.198418,"twenty":15.679949,"median":20.069656,"eighty":30.612845,"marketCap":4922913657},{"date":"2021-02-26","current":26.948508,"twenty":15.757032,"median":20.101665,"eighty":30.612845,"marketCap":4877680001},{"date":"2021-03-05","current":28.764142,"twenty":16.078184,"median":20.131636,"eighty":30.613864,"marketCap":5206309765},{"date":"2021-03-12","current":30.119103,"twenty":16.146147,"median":20.17181,"eighty":30.613864,"marketCap":5451557630},{"date":"2021-03-19","current":30.222173,"twenty":16.146147,"median":20.191936,"eighty":30.619304,"marketCap":5470213373},{"date":"2021-03-26","current":30.595804,"twenty":16.155113,"median":20.208951,"eighty":30.618171,"marketCap":5537840438},{"date":"2021-04-01","current":30.605466,"twenty":16.155113,"median":20.23058,"eighty":30.618171,"marketCap":5539589413},{"date":"2021-04-09","current":30.682769,"twenty":16.146147,"median":20.256725,"eighty":30.624072,"marketCap":5553581220},{"date":"2021-04-16","current":30.421872,"twenty":16.146147,"median":20.279169,"eighty":30.659957,"marketCap":5506358873},{"date":"2021-04-23","current":30.705316,"twenty":16.146147,"median":20.301119,"eighty":30.68362,"marketCap":5557662164},{"date":"2021-04-30","current":30.296255,"twenty":16.155113,"median":20.344302,"eighty":30.707893,"marketCap":5483622187},{"date":"2021-05-07","current":25.569844,"twenty":16.155113,"median":20.376409,"eighty":30.707893,"marketCap":5794126672},{"date":"2021-05-14","current":25.399722,"twenty":16.199938,"median":20.42789,"eighty":30.707893,"marketCap":5755577038},{"date":"2021-05-21","current":24.309395,"twenty":16.338001,"median":20.491036,"eighty":30.707893,"marketCap":5508508935},{"date":"2021-05-28","current":24.613553,"twenty":16.445582,"median":20.602521,"eighty":30.707893,"marketCap":5577431007},{"date":"2021-06-04","current":24.257843,"twenty":16.445582,"median":20.635149,"eighty":30.707893,"marketCap":5496827228},{"date":"2021-06-11","current":23.729434,"twenty":16.445582,"median":20.724193,"eighty":30.707893,"marketCap":5377089732},{"date":"2021-06-18","current":22.296285,"twenty":16.445582,"median":20.784488,"eighty":30.707893,"marketCap":5052338277},{"date":"2021-06-25","current":23.739744,"twenty":16.445582,"median":20.844829,"eighty":30.707893,"marketCap":5379426073},{"date":"2021-07-02","current":24.116075,"twenty":16.637435,"median":20.901381,"eighty":30.707893,"marketCap":5464702534},{"date":"2021-07-09","current":24.409922,"twenty":17.169936,"median":20.986777,"eighty":30.707893,"marketCap":5531288264},{"date":"2021-07-16","current":23.314439,"twenty":17.256001,"median":21.022105,"eighty":30.707893,"marketCap":5283051990},{"date":"2021-07-23","current":23.799029,"twenty":17.256001,"median":21.108637,"eighty":30.707893,"marketCap":5392860036},{"date":"2021-07-30","current":16.221256,"twenty":15.768581,"median":21.108637,"eighty":30.707893,"marketCap":5679061858},{"date":"2021-08-06","current":16.529487,"twenty":15.768581,"median":21.108637,"eighty":30.707893,"marketCap":5786973465},{"date":"2021-08-13","current":17.085494,"twenty":15.768581,"median":21.108637,"eighty":30.707893,"marketCap":5981631539},{"date":"2021-08-20","current":16.514415,"twenty":15.768581,"median":21.108637,"eighty":30.707893,"marketCap":5781696589},{"date":"2021-08-27","current":17.391968,"twenty":15.768581,"median":21.108637,"eighty":30.707893,"marketCap":6088928007},{"date":"2021-09-03","current":16.290002,"twenty":15.768581,"median":21.108637,"eighty":30.707893,"marketCap":5703129776},{"date":"2021-09-10","current":15.723947,"twenty":15.757032,"median":21.108637,"eighty":30.707893,"marketCap":5504953785},{"date":"2021-09-17","current":15.378954,"twenty":15.742757,"median":21.108637,"eighty":30.707893,"marketCap":5384171968},{"date":"2021-09-24","current":15.594993,"twenty":15.679949,"median":21.108637,"eighty":30.707893,"marketCap":5459807184},{"date":"2021-10-01","current":16.263207,"twenty":15.679949,"median":21.108637,"eighty":30.707893,"marketCap":5693748664},{"date":"2021-10-08","current":16.043818,"twenty":15.679949,"median":21.108637,"eighty":30.707893,"marketCap":5616940810},{"date":"2021-10-15","current":15.605042,"twenty":15.643409,"median":21.108637,"eighty":30.707893,"marketCap":5463325101},{"date":"2021-10-22","current":15.794285,"twenty":15.639757,"median":21.108637,"eighty":30.707893,"marketCap":5529579204},{"date":"2021-10-29","current":14.76593,"twenty":15.597281,"median":21.108637,"eighty":30.707893,"marketCap":6055507796},{"date":"2021-11-05","current":15.208034,"twenty":15.546124,"median":21.108637,"eighty":30.707893,"marketCap":6236814727},{"date":"2021-11-12","current":15.298251,"twenty":15.518993,"median":21.108637,"eighty":30.707893,"marketCap":6273812781},{"date":"2021-11-19","current":14.851461,"twenty":15.463133,"median":21.108637,"eighty":30.707893,"marketCap":6090584325},{"date":"2021-11-26","current":14.333071,"twenty":15.432575,"median":21.108637,"eighty":30.707893,"marketCap":5877992336},{"date":"2021-12-03","current":14.039507,"twenty":15.386249,"median":21.108637,"eighty":30.707893,"marketCap":5757601844},{"date":"2021-12-10","current":14.812797,"twenty":15.373275,"median":21.108637,"eighty":30.707893,"marketCap":6074728017},{"date":"2021-12-17","current":13.748807,"twenty":15.338429,"median":21.108637,"eighty":30.707893,"marketCap":5638385894},{"date":"2021-12-23","current":14.274358,"twenty":15.317813,"median":21.108637,"eighty":30.707893,"marketCap":5853914237},{"date":"2021-12-31","current":14.567922,"twenty":15.293897,"median":21.108637,"eighty":30.707893,"marketCap":5974304729},{"date":"2022-01-07","current":15.013279,"twenty":15.255263,"median":21.086933,"eighty":30.706604,"marketCap":6156945913},{"date":"2022-01-14","current":15.296819,"twenty":15.234158,"median":21.086933,"eighty":30.706604,"marketCap":6273225510},{"date":"2022-01-21","current":14.26147,"twenty":15.159469,"median":21.086933,"eighty":30.706604,"marketCap":5848628801},{"date":"2022-01-28","current":13.473236,"twenty":15.141331,"median":21.086933,"eighty":30.706604,"marketCap":5866246922},{"date":"2022-02-04","current":13.791554,"twenty":15.108005,"median":21.086933,"eighty":30.706604,"marketCap":6004842805},{"date":"2022-02-11","current":13.714672,"twenty":15.072408,"median":21.086933,"eighty":30.706604,"marketCap":5971368375},{"date":"2022-02-18","current":13.760532,"twenty":15.03684,"median":21.086933,"eighty":30.706604,"marketCap":5991335579},{"date":"2022-02-25","current":13.698487,"twenty":15.01748,"median":21.086933,"eighty":30.706604,"marketCap":5964321127},{"date":"2022-03-04","current":13.275413,"twenty":15.000697,"median":21.086933,"eighty":30.706604,"marketCap":5780114910},{"date":"2022-03-11","current":13.404745,"twenty":14.95296,"median":21.086933,"eighty":30.706604,"marketCap":5836425811},{"date":"2022-03-18","current":14.316596,"twenty":14.909849,"median":21.086933,"eighty":30.706604,"marketCap":6233446103},{"date":"2022-03-25","current":14.323128,"twenty":14.844637,"median":21.086933,"eighty":30.706604,"marketCap":6236290088},{"date":"2022-04-01","current":14.200329,"twenty":14.811668,"median":21.086933,"eighty":30.706604,"marketCap":6182823172},{"date":"2022-04-08","current":13.370779,"twenty":14.787157,"median":21.086933,"eighty":30.706604,"marketCap":5821637090},{"date":"2022-04-14","current":13.605352,"twenty":14.765711,"median":21.086933,"eighty":30.706604,"marketCap":5923770233},{"date":"2022-04-22","current":13.520383,"twenty":14.746344,"median":21.086933,"eighty":30.706604,"marketCap":5886774696},{"date":"2022-04-29","current":12.486253,"twenty":14.722676,"median":21.019089,"eighty":30.706604,"marketCap":5394061408},{"date":"2022-05-06","current":12.456696,"twenty":14.697062,"median":20.987955,"eighty":30.706604,"marketCap":5381292864},{"date":"2022-05-13","current":11.781959,"twenty":14.669658,"median":20.987955,"eighty":30.706604,"marketCap":5089806167},{"date":"2022-05-20","current":11.653499,"twenty":14.65307,"median":20.987955,"eighty":30.706604,"marketCap":5034311584},{"date":"2022-05-27","current":12.38533,"twenty":14.632214,"median":20.987955,"eighty":30.706604,"marketCap":5350462540},{"date":"2022-06-03","current":12.325642,"twenty":14.611294,"median":20.987955,"eighty":30.706604,"marketCap":5324677178},{"date":"2022-06-10","current":11.976595,"twenty":14.57907,"median":20.987955,"eighty":30.706604,"marketCap":5173888868},{"date":"2022-06-17","current":10.930751,"twenty":14.551074,"median":20.987955,"eighty":30.706604,"marketCap":4722084488},{"date":"2022-06-24","current":11.496493,"twenty":14.512301,"median":20.989133,"eighty":30.707893,"marketCap":4966484872},{"date":"2022-07-01","current":11.448483,"twenty":14.475592,"median":20.989133,"eighty":30.707893,"marketCap":4945744472},{"date":"2022-07-08","current":11.682046,"twenty":14.446312,"median":20.989133,"eighty":30.707893,"marketCap":5046643714},{"date":"2022-07-15","current":11.634035,"twenty":14.405366,"median":20.901381,"eighty":30.707893,"marketCap":5025903314},{"date":"2022-07-22","current":12.2945,"twenty":14.378471,"median":20.826627,"eighty":30.707893,"marketCap":5311223946},{"date":"2022-07-29","current":10.048078,"twenty":14.354753,"median":20.788925,"eighty":30.707893,"marketCap":5545534406},{"date":"2022-08-05","current":10.145269,"twenty":14.322523,"median":20.788925,"eighty":30.707893,"marketCap":5599173918},{"date":"2022-08-12","current":10.721601,"twenty":14.301896,"median":20.788925,"eighty":30.707893,"marketCap":5917251426},{"date":"2022-08-19","current":10.554902,"twenty":14.25908,"median":20.788925,"eighty":30.707893,"marketCap":5825250171},{"date":"2022-08-26","current":9.974504,"twenty":14.187553,"median":20.788925,"eighty":30.707893,"marketCap":5504928730},{"date":"2022-09-02","current":9.465258,"twenty":14.135304,"median":20.788925,"eighty":30.707893,"marketCap":5223876117},{"date":"2022-09-09","current":9.759015,"twenty":14.102002,"median":20.788925,"eighty":30.707893,"marketCap":5386000279},{"date":"2022-09-16","current":9.233506,"twenty":14.059394,"median":20.788925,"eighty":30.707893,"marketCap":5095971933},{"date":"2022-09-23","current":8.782199,"twenty":14.031264,"median":20.788925,"eighty":30.707893,"marketCap":4846895366},{"date":"2022-09-30","current":8.898075,"twenty":13.970918,"median":20.788925,"eighty":30.707893,"marketCap":4910847458},{"date":"2022-10-07","current":9.505917,"twenty":13.919195,"median":20.788925,"eighty":30.707893,"marketCap":5246315447},{"date":"2022-10-14","current":9.625859,"twenty":13.853034,"median":20.788925,"eighty":30.707893,"marketCap":5312511472},{"date":"2022-10-21","current":10.108676,"twenty":13.814554,"median":20.788925,"eighty":30.707893,"marketCap":5578978520},{"date":"2022-10-28","current":14.974971,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":5630588980},{"date":"2022-11-04","current":15.463609,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":5814316860},{"date":"2022-11-11","current":15.563653,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":5851933626},{"date":"2022-11-18","current":15.647273,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":5883374505},{"date":"2022-11-25","current":16.044465,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":6032718681},{"date":"2022-12-02","current":15.78614,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":5935588822},{"date":"2022-12-09","current":14.866328,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":5589739152},{"date":"2022-12-16","current":14.373571,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":5404462543},{"date":"2022-12-23","current":14.855875,"twenty":13.814554,"median":20.344302,"eighty":30.707893,"marketCap":5585809042},{"date":"2022-12-30","current":14.999223,"twenty":13.814554,"median":19.765377,"eighty":30.707893,"marketCap":5639707692},{"date":"2023-01-06","current":15.569626,"twenty":13.814554,"median":19.464991,"eighty":30.682769,"marketCap":5854179403},{"date":"2023-01-13","current":16.083288,"twenty":13.814554,"median":19.115452,"eighty":30.607602,"marketCap":6047316232},{"date":"2023-01-20","current":16.159441,"twenty":13.814554,"median":18.427296,"eighty":30.461812,"marketCap":6075949889},{"date":"2023-01-27","current":15.870494,"twenty":13.814554,"median":17.1977,"eighty":30.416074,"marketCap":6365655133},{"date":"2023-02-03","current":16.700552,"twenty":13.814554,"median":17.005108,"eighty":30.370928,"marketCap":6698591585},{"date":"2023-02-10","current":16.651561,"twenty":13.814554,"median":16.756543,"eighty":30.27693,"marketCap":6678941035},{"date":"2023-02-17","current":16.851727,"twenty":13.814554,"median":16.756543,"eighty":30.179893,"marketCap":6759227566},{"date":"2023-02-24","current":16.526982,"twenty":13.814554,"median":16.695284,"eighty":30.105575,"marketCap":6628972495},{"date":"2023-03-03","current":17.355997,"twenty":13.814554,"median":16.651561,"eighty":29.955493,"marketCap":6961490255},{"date":"2023-03-10","current":15.566371,"twenty":13.814554,"median":16.584753,"eighty":29.755722,"marketCap":6243671220},{"date":"2023-03-17","current":15.480547,"twenty":13.814554,"median":16.531531,"eighty":29.517526,"marketCap":6209247509},{"date":"2023-03-24","current":14.869936,"twenty":13.814554,"median":16.458394,"eighty":29.346477,"marketCap":5964331266},{"date":"2023-03-31","current":15.968755,"twenty":13.81764,"median":16.370108,"eighty":29.233228,"marketCap":6405067639},{"date":"2023-04-06","current":16.098193,"twenty":13.814554,"median":16.263207,"eighty":29.165128,"marketCap":6456985367},{"date":"2023-04-13","current":16.098193,"twenty":13.811468,"median":16.213847,"eighty":29.047766,"marketCap":6456985367},{"date":"2023-04-21","current":11.256514,"twenty":13.795287,"median":16.167243,"eighty":28.957812,"marketCap":4514987632},{"date":"2023-04-28","current":10.547063,"twenty":13.769342,"median":16.098193,"eighty":28.929603,"marketCap":4230427133},{"date":"2023-05-05","current":9.97455,"twenty":13.75401,"median":16.098193,"eighty":28.929603,"marketCap":4000792069},{"date":"2023-05-12","current":10.85153,"twenty":13.72131,"median":16.043818,"eighty":28.869244,"marketCap":4360144650},{"date":"2023-05-19","current":10.855892,"twenty":13.715462,"median":15.968755,"eighty":28.809081,"marketCap":4361897590},{"date":"2023-05-26","current":10.676792,"twenty":13.696628,"median":15.930768,"eighty":28.764729,"marketCap":4289934926},{"date":"2023-06-02","current":10.354878,"twenty":13.660339,"median":15.878021,"eighty":28.764729,"marketCap":4160590154},{"date":"2023-06-09","current":11.276849,"twenty":13.620925,"median":15.820484,"eighty":28.752181,"marketCap":4531038118},{"date":"2023-06-16","current":11.224609,"twenty":13.575222,"median":15.789127,"eighty":28.740612,"marketCap":4510047958},{"date":"2023-06-23","current":11.398273,"twenty":13.554976,"median":15.774827,"eighty":28.742195,"marketCap":4579826058},{"date":"2023-06-30","current":12.275063,"twenty":13.534076,"median":15.748467,"eighty":28.744691,"marketCap":4932120371},{"date":"2023-07-07","current":12.273651,"twenty":13.517745,"median":15.73232,"eighty":28.744691,"marketCap":4931553069},{"date":"2023-07-14","current":12.851119,"twenty":13.480736,"median":15.69546,"eighty":28.744691,"marketCap":5163579436},{"date":"2023-07-21","current":13.091142,"twenty":13.444539,"median":15.669077,"eighty":28.744691,"marketCap":5260020713},{"date":"2023-07-28","current":28.047249,"twenty":13.437725,"median":15.657467,"eighty":28.744691,"marketCap":5306539447},{"date":"2023-08-04","current":27.615476,"twenty":13.437725,"median":15.657467,"eighty":28.744691,"marketCap":5224848012},{"date":"2023-08-11","current":26.895854,"twenty":13.437725,"median":15.657467,"eighty":28.744691,"marketCap":5088695621},{"date":"2023-08-18","current":25.936359,"twenty":13.437725,"median":15.657467,"eighty":28.744691,"marketCap":4907159099},{"date":"2023-08-25","current":26.047301,"twenty":13.437725,"median":15.657467,"eighty":28.735863,"marketCap":4928149259},{"date":"2023-09-01","current":27.32163,"twenty":13.437725,"median":15.657467,"eighty":28.633914,"marketCap":5169252452},{"date":"2023-09-08","current":25.936359,"twenty":13.437725,"median":15.657467,"eighty":28.427306,"marketCap":4907159099},{"date":"2023-09-15","current":26.131256,"twenty":13.437725,"median":15.657467,"eighty":28.310023,"marketCap":4944033705},{"date":"2023-09-22","current":25.732466,"twenty":13.437725,"median":15.657467,"eighty":28.103852,"marketCap":4868582588},{"date":"2023-09-29","current":26.778916,"twenty":13.437725,"median":15.657467,"eighty":28.040876,"marketCap":5066570857},{"date":"2023-10-06","current":25.921367,"twenty":13.437725,"median":15.657467,"eighty":27.952179,"marketCap":4904322591},{"date":"2023-10-13","current":26.404113,"twenty":13.437725,"median":15.657467,"eighty":27.770815,"marketCap":4995658153},{"date":"2023-10-20","current":25.186753,"twenty":13.437725,"median":15.657467,"eighty":27.598634,"marketCap":4765333692},{"date":"2023-10-27","current":17.482305,"twenty":13.425722,"median":15.649693,"eighty":27.611266,"marketCap":5309375955},{"date":"2023-11-03","current":18.634591,"twenty":13.425722,"median":15.649693,"eighty":27.611266,"marketCap":5659325216},{"date":"2023-11-10","current":18.896496,"twenty":13.425722,"median":15.649693,"eighty":27.611266,"marketCap":5738865978},{"date":"2023-11-17","current":19.770139,"twenty":13.421721,"median":15.647273,"eighty":27.615476,"marketCap":6004191234},{"date":"2023-11-24","current":20.363168,"twenty":13.421721,"median":15.647273,"eighty":27.615476,"marketCap":6184294245},{"date":"2023-12-01","current":19.770139,"twenty":13.421721,"median":15.647273,"eighty":27.615476,"marketCap":6004191234},{"date":"2023-12-08","current":19.455852,"twenty":13.425722,"median":15.649693,"eighty":27.611266,"marketCap":5908742320},{"date":"2023-12-15","current":20.419291,"twenty":13.425722,"median":15.649693,"eighty":27.611266,"marketCap":6201338694},{"date":"2023-12-22","current":21.33222,"twenty":13.425722,"median":15.649693,"eighty":27.611266,"marketCap":6478595064},{"date":"2023-12-29","current":22.136644,"twenty":13.421721,"median":15.647273,"eighty":27.615476,"marketCap":6722898833},{"date":"2024-01-05","current":21.592254,"twenty":13.419632,"median":15.645413,"eighty":27.624048,"marketCap":6557567678},{"date":"2024-01-12","current":21.081538,"twenty":13.419632,"median":15.645413,"eighty":27.624048,"marketCap":6402463192},{"date":"2024-01-19","current":21.749398,"twenty":13.417543,"median":15.643553,"eighty":27.632621,"marketCap":6605292135},{"date":"2024-01-26","current":21.257389,"twenty":13.419632,"median":15.645413,"eighty":27.624048,"marketCap":6455869132},{"date":"2024-02-02","current":28.058844,"twenty":13.419632,"median":15.669077,"eighty":27.669555,"marketCap":7180258215},{"date":"2024-02-09","current":28.169854,"twenty":13.419632,"median":15.704121,"eighty":27.796495,"marketCap":7208665630},{"date":"2024-02-16","current":27.308418,"twenty":13.419632,"median":15.733099,"eighty":27.825797,"marketCap":6988224090},{"date":"2024-02-23","current":27.148564,"twenty":13.419632,"median":15.755466,"eighty":27.825797,"marketCap":6947317412},{"date":"2024-03-01","current":27.092062,"twenty":13.441726,"median":15.777181,"eighty":27.812943,"marketCap":6932858665},{"date":"2024-03-08","current":29.888075,"twenty":13.445242,"median":15.789127,"eighty":27.963376,"marketCap":7648358285},{"date":"2024-03-15","current":28.812755,"twenty":13.445242,"median":15.827779,"eighty":28.043716,"marketCap":7373184090},{"date":"2024-03-22","current":30.106708,"twenty":13.445242,"median":15.896443,"eighty":28.076477,"marketCap":7704306565},{"date":"2024-03-28","current":30.093322,"twenty":13.445242,"median":15.930965,"eighty":28.169854,"marketCap":7700881160},{"date":"2024-04-05","current":30.22941,"twenty":13.444539,"median":15.993577,"eighty":28.367293,"marketCap":7735706111},{"date":"2024-04-12","current":30.521665,"twenty":13.444539,"median":16.063876,"eighty":28.550678,"marketCap":7810494118},{"date":"2024-04-19","current":28.866298,"twenty":13.444539,"median":16.098193,"eighty":28.738359,"marketCap":7386885709},{"date":"2024-04-26","current":38.231767,"twenty":13.445242,"median":16.102434,"eighty":28.817217,"marketCap":8219830006},{"date":"2024-05-03","current":37.612546,"twenty":13.445242,"median":16.172772,"eighty":28.907655,"marketCap":8086697428},{"date":"2024-05-10","current":38.354269,"twenty":13.445242,"median":16.221256,"eighty":29.130483,"marketCap":8246167924},{"date":"2024-05-17","current":38.702534,"twenty":13.445242,"median":16.290002,"eighty":29.281518,"marketCap":8321044752},{"date":"2024-05-24","current":38.854069,"twenty":13.445242,"median":16.385606,"eighty":29.401797,"marketCap":8353624746},{"date":"2024-05-31","current":39.239552,"twenty":13.454387,"median":16.514415,"eighty":29.631749,"marketCap":8436503678},{"date":"2024-06-07","current":37.902323,"twenty":13.473236,"median":16.552178,"eighty":29.829217,"marketCap":8148999521},{"date":"2024-06-14","current":38.593535,"twenty":13.469601,"median":16.648062,"eighty":29.922236,"marketCap":8297610020},{"date":"2024-06-21","current":37.928908,"twenty":13.465967,"median":16.735546,"eighty":30.031355,"marketCap":8154715310},{"date":"2024-06-28","current":38.468585,"twenty":13.455063,"median":16.771844,"eighty":30.093322,"marketCap":8270745814},{"date":"2024-07-05","current":38.447317,"twenty":13.455063,"median":16.814111,"eighty":30.119103,"marketCap":8266173184},{"date":"2024-07-12","current":38.896605,"twenty":13.455063,"median":16.946902,"eighty":30.175867,"marketCap":8362770008},{"date":"2024-07-15","current":39.090676,"twenty":13.455063,"median":17.002596,"eighty":30.222173,"marketCap":8404495263},{"date":"2024-08-02","current":36.716509,"twenty":13.443132,"median":17.163621,"eighty":30.257604,"marketCap":8848678588},{"date":"2024-08-09","current":34.544426,"twenty":13.474636,"median":17.391968,"eighty":30.380644,"marketCap":8325206621},{"date":"2024-08-16","current":35.878536,"twenty":13.516412,"median":18.180924,"eighty":30.441623,"marketCap":8646727108},{"date":"2024-08-23","current":35.80732,"twenty":13.536427,"median":18.692584,"eighty":30.507515,"marketCap":8629564092},{"date":"2024-08-30","current":37.015615,"twenty":13.564424,"median":19.093862,"eighty":30.613864,"marketCap":8920763252},{"date":"2024-09-06","current":35.370529,"twenty":13.617967,"median":19.465206,"eighty":30.68362,"marketCap":8524297599},{"date":"2024-09-13","current":35.593672,"twenty":13.654447,"median":19.770139,"eighty":30.724008,"marketCap":8578075046},{"date":"2024-09-20","current":36.657162,"twenty":13.697093,"median":19.955344,"eighty":30.811628,"marketCap":8834376075},{"date":"2024-09-27","current":37.647062,"twenty":13.718449,"median":20.170481,"eighty":31.202877,"marketCap":9072941988},{"date":"2024-10-04","current":37.063092,"twenty":13.754547,"median":20.419291,"eighty":33.022546,"marketCap":8932205262},{"date":"2024-10-11","current":36.813837,"twenty":13.782708,"median":20.788925,"eighty":33.919642,"marketCap":8872134709},{"date":"2024-10-18","current":38.748534,"twenty":13.844231,"median":21.132049,"eighty":34.498848,"marketCap":9338396624},{"date":"2024-10-25","current":35.731356,"twenty":13.972834,"median":21.270485,"eighty":35.063709,"marketCap":8611256876},{"date":"2024-10-31","current":35.156674,"twenty":14.041756,"median":21.392084,"eighty":35.155808,"marketCap":9249721045},{"date":"2024-11-08","current":37.821894,"twenty":14.04673,"median":21.716135,"eighty":35.381924,"marketCap":9950940184},{"date":"2024-11-15","current":37.830595,"twenty":14.04673,"median":21.871932,"eighty":35.703819,"marketCap":9953229467},{"date":"2024-11-22","current":39.842745,"twenty":14.04673,"median":22.117001,"eighty":35.842453,"marketCap":10482626124},{"date":"2024-11-29","current":39.607813,"twenty":14.04673,"median":22.252579,"eighty":36.21515,"marketCap":10420815487},{"date":"2024-12-06","current":38.322212,"twenty":14.04673,"median":22.415358,"eighty":36.508084,"marketCap":10082573948},{"date":"2024-12-13","current":36.138213,"twenty":14.04673,"median":22.859046,"eighty":36.698326,"marketCap":9507963955},{"date":"2024-12-20","current":33.179809,"twenty":14.04673,"median":23.30284,"eighty":36.698326,"marketCap":8729607789},{"date":"2024-12-27","current":34.026,"twenty":14.04673,"median":23.434298,"eighty":36.698326,"marketCap":8952240545},{"date":"2025-01-03","current":32.842638,"twenty":14.04673,"median":23.518071,"eighty":36.698326,"marketCap":8640898079},{"date":"2025-01-10","current":33.425618,"twenty":14.045235,"median":23.729434,"eighty":36.704639,"marketCap":8794280029},{"date":"2025-01-17","current":33.814996,"twenty":14.045235,"median":23.80934,"eighty":36.704639,"marketCap":8896725436},{"date":"2025-01-24","current":35.437768,"twenty":14.045235,"median":23.953686,"eighty":36.704639,"marketCap":9323676686},{"date":"2025-01-31","current":33.333263,"twenty":14.045235,"median":23.956263,"eighty":36.531348,"marketCap":9823312666},{"date":"2025-02-07","current":33.556598,"twenty":14.045235,"median":23.956263,"eighty":36.222746,"marketCap":9889129548},{"date":"2025-02-14","current":32.746766,"twenty":14.045235,"median":23.956263,"eighty":35.878536,"marketCap":9650471812},{"date":"2025-02-21","current":33.306075,"twenty":14.045235,"median":23.956263,"eighty":35.814441,"marketCap":9815300176},{"date":"2025-02-28","current":31.197014,"twenty":14.045235,"median":23.956263,"eighty":35.764062,"marketCap":9193759885},{"date":"2025-03-07","current":29.524826,"twenty":14.045214,"median":23.954974,"eighty":35.772714,"marketCap":8700966306},{"date":"2025-03-14","current":29.365117,"twenty":14.045214,"median":23.967817,"eighty":35.772714,"marketCap":8653899927},{"date":"2025-03-21","current":29.877642,"twenty":14.045214,"median":24.116075,"eighty":35.772714,"marketCap":8804941148},{"date":"2025-03-28","current":30.412112,"twenty":14.045214,"median":24.170205,"eighty":35.772714,"marketCap":8962449399},{"date":"2025-04-04","current":28.45369,"twenty":14.045214,"median":24.30281,"eighty":35.772714,"marketCap":8385302378},{"date":"2025-04-11","current":27.414009,"twenty":14.045235,"median":24.43312,"eighty":35.764062,"marketCap":8078908592},{"date":"2025-04-17","current":27.614923,"twenty":14.045235,"median":24.592932,"eighty":35.764062,"marketCap":8138117897},{"date":"2025-04-25","current":29.14811,"twenty":14.045214,"median":24.78754,"eighty":35.772714,"marketCap":8589948135},{"date":"2025-05-02","current":27.818973,"twenty":14.045214,"median":24.78754,"eighty":35.772714,"marketCap":9374993854},{"date":"2025-05-09","current":28.96729,"twenty":14.045214,"median":24.78754,"eighty":35.772714,"marketCap":9761976856},{"date":"2025-05-16","current":30.05077,"twenty":14.045214,"median":24.915132,"eighty":35.772714,"marketCap":10127109406},{"date":"2025-05-23","current":29.127679,"twenty":14.045214,"median":24.915132,"eighty":35.772714,"marketCap":9816027974},{"date":"2025-05-30","current":29.564484,"twenty":14.045214,"median":24.915132,"eighty":35.772714,"marketCap":9963231018},{"date":"2025-06-06","current":29.840899,"twenty":14.045214,"median":24.915132,"eighty":35.772714,"marketCap":10056382944},{"date":"2025-06-10","current":31.734855,"twenty":14.045214,"median":24.915132,"eighty":35.772714,"marketCap":10694646142}],"updateTime":1749647385957}}}